IP Library › Granted Patent US 11,452,557
Granted Patent B2
US 11,452,557 · App. 16/070,495 · Granted Sep 27, 2022

RF treatment apparatus, method of controlling RF treatment apparatus and skin treatment method using RF energy

Inventors: Kwang Chon Ko (Paju, KR); Richard Howard Cohen (San Rafael, CA)
Assignee: LUTRONIC CORPORATION
A61B18/1206A61B18/14A61B2018/00452A61B2018/00678A61B2018/00714A61B2018/00767A61B2018/00779A61B2018/00827A61B2018/00875A61B2018/00892
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,452,557
App. No.
16/070,495
Granted
Sep 27, 2022
Kind
B2
Abstract

The present invention relates to an RF treatment apparatus, the method of controlling the RF treatment apparatus and the skin treatment method using RF energy according to the present invention have an effect in that they can improve the accuracy and efficiency of treatment because whether a target tissue corresponds to a treatment temperature is determined based on impedance of the tissue and the volume of the target tissue corresponding to the treatment temperature can be maximized while maintaining the target tissue to the treatment temperature for a predetermined time.

Claims (39)

1. An RF treatment apparatus, comprising:

an RF generator generating RF energy;

an electrode applying the RF energy for a target tissue;

a sensor unit configured to sense the RF energy; and

a controller that is configured to:

control output of the RF generator,

receive a sensing value from the sensor unit,

calculate impedance of the target tissue,

determine when the target tissue that is denatured by the RF energy is in a coagulation phase, and determine that a transition from the coagulation phase to an ablation phase is occurring for a specific period after an initial period, and

cut off the RF energy before the tissue enters the ablation phase, wherein the controller determines whether the tissue transition is occurring based on a rate of change of impedance, and the rate of change of impedance is determined using a product or average of impedance values measured in three consecutive time periods.

2. The RF treatment apparatus of claim 1 , wherein:

the controller determines that the transition from the coagulation phase to the ablation phase is occurring when a parameter exceeds a threshold, and

wherein the parameter is based on the rate of change of impedance.

3. The RF treatment apparatus of claim 2 , wherein the parameter is defined as a product of a rising time in which impedance increases for the three consecutive time periods and the rate of change of impedance for the rising time.

4. The RF treatment apparatus of claim 2 , wherein the parameter is defined as a product of a specific time and an average of rate of change of impedance up to the specific time.

5. The RF treatment apparatus of claim 2 , wherein:

the sensor unit measures current, a voltage and power applied to the electrode, and

the controller calculates the rate of change of impedance as a root mean square (RMS) when calculating the impedance.

6. The RF treatment apparatus of claim 5 , wherein the controller controls an output voltage of the RF generator so that the power does not exceed a specific range.

7. The RF treatment apparatus of claim 2 , wherein the electrode comprises at least one of a contact type and an insertion type.

8. The RF treatment apparatus of claim 1 , wherein the controller is further configured to perform in a coagulation mode in which the controller is configured to determine that the transition from the coagulation phase to an ablation phase is occurring for a specific period after an initial period, and reduce the amount of RF energy applied by the electrode at a predetermined time to maintain the coagulation phase without entering the ablation phase.

9. A method of controlling an RF treatment apparatus, comprising steps of:

applying RF energy to a tissue through an electrode;

calculating impedance of the tissue for a plurality of time periods;

calculating a parameter based on a rate of change of impedance using impedance values or changes for at least three consecutive time periods of the plurality of time periods during which RF energy is applied;

determining that a transition from a coagulation phase to an ablation phase is occurring after an initial period by comparing the parameter to a threshold; and

cutting off the RF energy when the parameter exceeds the threshold.

10. The method of claim 9 , wherein the parameter is defined as a product of a rising time from a current time to a specific time and the rate of change of impedance for the rising time.

11. The method of claim 9 , wherein the parameter is defined as a product of a rising time from a current time to a predetermined time before and an average of rate of change of impedance for the rising time.

12. The method of claim 9 , wherein the step of determining whether the parameter exceeds the threshold is performed after a specific time from a point of time at which the RF energy is applied.

13. The method of claim 9 , wherein the step of positioning the electrode in the tissue is performed by at least one of a contact and insertion of the electrode on and into the tissue.

14. A skin treatment method using RF energy, comprising steps of:

positioning an electrode in a tissue;

heating the tissue to a treatment temperature by applying RF energy to the electrode;

measuring the RF energy applied to the tissue for a plurality of time periods;

calculating a rate of change of impedance of the tissue to which the RF energy is applied using a product or average of impedance changes for at least three consecutive time periods of the plurality of time periods;

comparing a parameter based on the rate of change in the impedance of the tissue to a threshold;

determining that a transition from a coagulation phase to an ablation phase is occurring after an initial period when the parameter exceeds a threshold; and

cutting off the RF energy when the transition occurs in the tissue based on a result of the comparison between the parameter and the threshold in order to prevent ablation of the tissue.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2018
From: KO, KWANG CHON; COHEN, RICHARD HOWARD
To: LUTRONIC CORPORATION
Reel/Frame 046368/0503 →
Priority Claims (1)
KR 10-2017-0041801 · Mar 31, 2017 · national
Continuity (1)
Related Publication 20210196342A1 · Jul 1, 2021